Tag: LILLY DRN

Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro

April 24, 2025 Admin No Comments

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters Eli Lilly is suing four telehealth companies selling compounded versions of the pharmaceutical giant’s weight loss drug Zepbound and its diabetes treatment Mounjaro, the company’s latest attempt to crack down on…

Health

Trump drops Biden’s proposal for Medicare to cover obesity drugs like Wegovy and Zepbound

April 4, 2025 Admin No Comments

A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Reuters President Donald Trump on Friday dropped a Biden administration proposal to have Medicare cover obesity drugs, including popular but costly GLP-1 treatments such as Novo Nordisk‘s Wegovy and Eli Lilly‘s Zepbound. But the Centers…

Health

Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau

November 26, 2024 Admin No Comments

The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama | Getty Images Amgen on Tuesday said its experimental weight loss injection helped patients with obesity lose up to 20% of their weight on average after a year in a critical mid-stage trial, as the company races…

Health

Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca

November 8, 2024 Admin No Comments

Aykut Karahan | Istock | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Happy Friday! Buried in the election news this week was new data from drugmakers vying to enter the booming weight…

Health